🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

A Transdiagnostic, Self-guided Internet Intervention ("Velibra") for Waitlist Patients With Anxiety Disorders

RecruitingNAAges 18 Years - 65 YearsAllCharite University, Berlin, Germany
NCT04793828 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The project's aim is to investigate the effect of a transdiagnostic, self-guided, internet-based cognitive behavioral therapy program in waitlist patients with anxiety disorders.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Diagnosis of panic disorder with or without agoraphobia, social anxiety disorder, or generalized anxiety disorder * Knowledge of German that is sufficient for engaging with the treatment and responding to the questionnaires * Written informed consent * Internet access Exclusion Criteria: * Diagnoses of severe mental comorbidities (e.g., schizophrenia, severe major depression, borderline personality disorder) * Acute suicidality * Started or changed anxiolytic pharmacotherapy recently (currently or in the past four weeks)
💊

What it tests

  • Velibra
📍

Where

1 site
Department of Psychiatry and Psychotherapy, Charité Campus Mitte - Universitätsmedizin Berlin
Berlin, Germany
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy